David Musto's landmark historical analysis traces cannabis prohibition to Harry Anslinger's racially motivated propaganda campaign in the 1930s, demonstrating that marijuana's Schedule I status was built on politics and prejudice, not pharmacological evidence.
Anyone seeking to understand why cannabis is illegal, how racial politics shaped drug policy, or why reform has been so slow. Essential background for policymakers, advocates, and anyone arguing about cannabis scheduling.
The AMA testified against the Marihuana Tax Act of 1937, telling Congress there was no evidence marijuana was a dangerous drug. The Committee did not even thank them for their testimony.
The Backstory
To understand why cannabis is illegal, you don't need pharmacology. You need history.
In 1973, a Yale psychiatrist and historian named David Musto published a book that would become the definitive account of how the United States built its drug prohibition regime. The American Disease: Origins of Narcotic Control traced the tangled history of American drug policy from the post-Civil War patent medicine era through the Nixon-era Controlled Substances Act — and showed, with meticulous archival research, that the framework was built on racial prejudice, institutional ambition, and political convenience rather than scientific evidence.
The cannabis chapters are the most explosive. Musto documented, in primary sources, how one man — Harry Anslinger — manufactured a crisis to justify his agency's existence and used explicitly racist propaganda to turn marijuana from an unregulated plant into a Schedule I narcotic. The New York Times Book Review called the book "mandatory reading for anyone who wants to understand how we got into our present mess." It still is.
Harry Anslinger: The Man Who Criminalized Cannabis
Harry Jacob Anslinger became the first commissioner of the Federal Bureau of Narcotics in 1930. He would hold the position for 32 years — the longest tenure of any federal law enforcement chief in American history. When he took office, marijuana was essentially legal. When he left, it was the most feared drug in America.
Research Timeline
From Legal Plant to Schedule I Narcotic
Anslinger appointed FBN commissioner
Anslinger launches anti-marijuana campaign
"Reefer Madness" propaganda era
Marihuana Tax Act passes Congress
Anslinger retires
Controlled Substances Act
Shafer Commission recommends decriminalization
Musto (1999), The American Disease; historical record
The most important thing Musto established is that Anslinger's campaign was not a response to a genuine public health crisis. Marijuana was not causing mass insanity or widespread violence. Anslinger manufactured the crisis because his agency needed one.
The Racist Foundation
Anslinger's anti-marijuana campaign relied on explicitly racist messaging that would be immediately recognized as such today. Among his statements to Congress and in published articles:
"Reefer makes darkies think they're as good as white men."
"There are 100,000 total marijuana smokers in the US, and most are Negroes, Hispanics, Filipinos and entertainers. Their Satanic music, jazz and swing, result from marijuana usage."
"Coloreds with big lips lure white women with jazz and marijuana."
These weren't marginal remarks — they were the core of the political case for prohibition. Musto showed that Anslinger deliberately linked marijuana to feared minority groups because he understood that racial anxiety was a more powerful political tool than pharmacological evidence (of which he had none).
The racial framing followed a pattern Musto identified across American drug policy: each wave of drug prohibition was associated with a feared ethnic minority. Opium was linked to Chinese immigrants. Cocaine was linked to Black Americans in the South. Marijuana was linked to Mexican immigrants in the Southwest and Black jazz musicians in cities. The pharmacology was incidental. The prejudice was structural.
The AMA Fought Back — and Lost
Harry Anslinger (Federal Bureau of Narcotics)
Testified that marijuana caused insanity, violence, and moral depravity. Presented 'Gore Files' — a collection of anecdotes linking marijuana use to violent crimes. Many of these were later proven to be fabricated or misattributed (notably the Licata family murder case, caused by severe mental illness, not marijuana). Anslinger provided no controlled scientific data.
Dr. William C. Woodward (American Medical Association)
Testified that the AMA 'knows of no evidence that marijuana is a dangerous drug.' Argued that cannabis had legitimate medical uses. Pointed out that no relevant federal agencies (Public Health Service, Children's Bureau) had been consulted for data. Accused the Bureau of Narcotics of providing no actual evidence for its claims.
Congressional hearing transcript, 1937; Musto (1999)
The AMA's opposition deserves to be remembered because it demonstrates how thoroughly politics overrode science. Dr. William C. Woodward, the AMA's legislative counsel, was the only medical expert to testify against the Marihuana Tax Act. He told the House Ways and Means Committee that the Bureau's claims about marijuana-induced violence and insanity were unsupported. He argued that the proposed law would burden physicians and pharmacists and interfere with medical research.
The Committee's response was hostile. After Woodward's testimony, a committee member reportedly responded: "If you want to advise us on legislation, you ought to come here with some constructive proposals rather than criticism, rather than trying to throw obstacles in the way of something that the Federal Government is trying to do."
The Act passed. The AMA was ignored. Eighty-eight years later, cannabis remains in Schedule I.
Why This History Matters Now
Every feature of the current cannabis policy landscape traces back to decisions Musto documented:
Process
From 1937 to Today: The Chain of Consequences
Cannabis sits alongside heroin and above cocaine and methamphetamine — not because of its pharmacology, but because of a political decision made in 1970 building on Anslinger's framework. This classification makes federal research nearly impossible and prevents physicians from prescribing it.
Schedule I status requires special DEA licensing for research. For decades, NIDA was the sole source of research-grade cannabis — and NIDA's mission is to study drug abuse, creating a structural bias toward harm-finding research.
The racial framing Anslinger pioneered is encoded in enforcement patterns. Black Americans are arrested for marijuana at 3.7x the rate of white Americans despite similar usage — a direct legacy of policing structures built during prohibition.
Millions of Americans carry marijuana convictions that affect employment, housing, education, and immigration — consequences that fall disproportionately on the communities Anslinger targeted.
Marijuana is legal in 24+ states but remains a Schedule I federal felony, creating legal chaos for businesses, patients, veterans, and immigrants caught between jurisdictions.
Synthesis of Musto (1999) and current policy
David Musto: The Historian as Public Intellectual
David Franklin Musto (1936-2010) was uniquely positioned to write this history. He held both an MD from the University of Washington and a master's in History of Science from Yale. As Professor of Child Psychiatry and the History of Medicine at Yale School of Medicine, he bridged the gap between clinical understanding of substances and historical understanding of how societies regulate them.
In 1978, President Jimmy Carter appointed Musto to the White House Strategy Council on Drug Abuse — making him one of the rare academic historians to directly advise on the policy he studied. His cyclical theory of drug policy — that American society alternates between periods of tolerance and periods of prohibition, driven more by cultural anxiety than pharmacological evidence — has been cited by reformers and prohibitionists alike, though the implications tend to favor reform.
Musto died in October 2010 in Shanghai, where he was donating his papers to Shanghai University for a new Center for International Drug Control Policy Studies. He did not live to see the legalization wave that began two years later — but his work predicted it.
The Cyclical Pattern
The cyclical theory is both hopeful and cautionary. It suggests that legalization will likely continue to expand — but also that a future backlash is possible if public anxiety about cannabis (perhaps related to youth use, potency, or mental health effects) builds to a critical threshold. Understanding the cycle doesn't break it, but it does provide the historical literacy to recognize when political forces are manipulating drug policy for purposes unrelated to public health.
Who was Harry Anslinger?
Harry Jacob Anslinger (1892-1975) was the first commissioner of the Federal Bureau of Narcotics, serving from 1930 to 1962 — the longest tenure of any federal law enforcement chief. He transformed marijuana from an unregulated plant into the most feared drug in America through a propaganda campaign that explicitly used racist rhetoric linking cannabis to Mexican immigrants and Black Americans. His testimony and fabricated evidence were the basis for the Marihuana Tax Act of 1937.
Why did the AMA oppose the Marihuana Tax Act?
Dr. William C. Woodward, the AMA's legislative counsel, testified that the AMA "knows of no evidence that marijuana is a dangerous drug." He argued that cannabis had legitimate medical uses, that the bill was drafted without consulting the medical profession, and that the Bureau of Narcotics had provided no scientific data to support its claims. The congressional committee responded with hostility and passed the Act over the AMA's objections.
How did marijuana end up in Schedule I?
The Controlled Substances Act of 1970 placed marijuana in Schedule I — the most restrictive category, reserved for drugs with "high abuse potential and no accepted medical use." This was supposed to be temporary, pending review by the Shafer Commission. When the Commission recommended decriminalization in 1972, President Nixon rejected the recommendation. The classification has persisted for over 50 years, creating massive barriers to research, medical use, and rational policy.
Is 'The American Disease' still relevant?
More than ever. The historical dynamics Musto documented — racial anxiety driving drug policy, political decisions overriding science, cyclical patterns of tolerance and prohibition — are actively playing out in today's rescheduling debates, equity programs, and federal-state conflicts. Every policy discussion about cannabis is, whether participants realize it or not, a chapter in the story Musto told.
Were there economic motivations for prohibition beyond racism?
Some historians argue that competition between hemp fiber and synthetic fibers (nylon, patented by DuPont in 1935) also motivated prohibition, with industrialists like William Randolph Hearst and the DuPont family allegedly supporting Anslinger's campaign. Musto acknowledged economic factors but argued that racial anxiety was the primary political fuel. The debate continues, but the racist framing of the legislative campaign is documented in primary sources and is not contested.
The American Disease: Origins of Narcotic Control (Third Edition)
Musto, David F. (1999) · Oxford University Press
What the researchers found
Cannabis prohibition in the United States originated from Harry Anslinger's racially motivated propaganda campaign in the 1930s, not from scientific evidence of harm. The Marihuana Tax Act of 1937 was passed over the objections of the AMA and without meaningful scientific input, establishing a prohibition framework that persists in modified form today.
Why it matters
Understanding the origins of cannabis prohibition explains why marijuana was placed in Schedule I (alongside heroin, above cocaine and methamphetamine) despite pharmacological evidence that it doesn't belong there. The scheduling wasn't based on science — it was based on politics. Every drug test, every criminal record, every research barrier traces back to a policy framework Musto documented as rooted in racism.
How the study worked
Historical analysis using primary sources including government archives (FBN records, congressional hearing transcripts, presidential papers), newspaper archives, medical journals, and institutional documents. Musto's approach combined his training in psychiatry, history of medicine, and public policy to analyze the interplay between science, politics, race, and institutional power in shaping drug regulation.
Who was studied
Historical analysis of US drug policy from post-Civil War to late 20th century, with primary source research including government archives, congressional records, and institutional documents.
What this study cannot tell us
This is a historical analysis, not a scientific study. It is subject to the interpretive frameworks and source limitations inherent in historical scholarship. Some critics argue that Musto overstates the racial motivation and understates economic factors (hemp competition with synthetic fibers) in cannabis prohibition. The third edition (1999) predates the modern legalization movement.
How to read the evidence
Strong evidence as historical scholarship. Based on extensive primary source research (government archives, congressional records, institutional documents) by a credentialed historian at Yale with government advisory experience. The book has been the standard reference on US drug policy history for over 50 years. Not a clinical or epidemiological study — it's a work of history.
When this study was published
Third edition published 1999 (original 1973). Musto died in 2010. The book covers history through the late 1990s but not the modern legalization era (2012 onward). The historical analysis of prohibition origins remains fully relevant.
The bigger picture
Musto's work is the historical foundation for the racial equity arguments in modern cannabis reform. The ACLU's arrest disparity data, social equity licensing provisions, and expungement programs all respond to a prohibition regime that Musto showed was built on racial animus. His cyclical theory of drug policy — tolerance followed by prohibition followed by tolerance — also predicted the legalization wave that began after his death in 2010.
Funding
Academic (Yale University)
Conflicts of interest
None. Musto served as presidential drug policy adviser under Carter.
Questions still open
- Has the cyclical pattern Musto identified continued into the legalization era?
- To what extent has racial equity been achieved in the transition from prohibition to legalization?
- How should the racial origins of prohibition inform modern policy design?
- Will the US complete the cycle to tolerance or oscillate again?
- How does international cannabis policy relate to the specifically American dynamics Musto described?
Common questions
Who was Harry Anslinger?
Why did the AMA oppose the Marihuana Tax Act?
How did marijuana end up in Schedule I?
Is The American Disease still relevant?
Read the original research
The American Disease: Origins of Narcotic Control (Third Edition)
Oxford University Press, Third Edition
Oxford University Press academic book. First published 1973, expanded 1987, third edition 1999. Called "mandatory reading" by the New York Times Book Review.
Citation
Musto, David F.. (1999). The American Disease: Origins of Narcotic Control (Third Edition). Oxford University Press, Third Edition.